References
Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer Oxf Engl 46:765–781. doi:10.1016/j.ejca.2009.12.014
Rosario DJ, Lane JA, Metcalfe C et al (2012) Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within Protec T study. Br Med J 344:d7894–d7894. doi:10.1136/bmj.d7894
Heidenreich A, Bastian PJ, Bellmunt J et al (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65:124–137. doi:10.1016/j.eururo.2013.09.046
American Urological Association Best practice policy statement on urologic surgery antimicrobial prophylaxis (2008) (Updated January 2014).
Turnidge J (1999) Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs 58(Suppl 2):29–36
Nam RK, Saskin R, Lee Y et al (2013) Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 189:S12–S17. doi:10.1016/j.juro.2012.11.015 (discussion S17–18)
Raaijmakers R, Kirkels WJ, Roobol MJ et al (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60:826–830
Zaytoun OM, Vargo EH, Rajan R et al (2011) Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 77:1035–1041. doi:10.1016/j.urology.2010.12.067
Kim JB, Jung SI, Hwang EC, Kwon DD (2014) Prevalence of antibiotic-resistant bacteria on rectal swabs and factors affecting resistance to antibiotics in patients undergoing prostate biopsy. Korean J Urol 55:201–206. doi:10.4111/kju.2014.55.3.201
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lodeta, B., Trkulja, V. Septic complications and hospital admissions after transrectal ultrasound-guided prostate biopsy: incidence rates and outcomes in 913 consecutive biopsies. Int Urol Nephrol 46, 2335–2336 (2014). https://doi.org/10.1007/s11255-014-0815-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0815-x